Combined coronary artery bypass graft and liver/kidney transplantation in a liver failure patient with acute on chronic kidney failure and antiphospholipid syndrome

Emily Lin; Charles Bratton; Minh-Tri Nguyen; Joshua Chung; Michael De Vera; Mina Rakoski

doi:10.1111/ajt.17067

Combined coronary artery bypass graft and liver/kidney transplantation in a liver failure patient with acute on chronic kidney failure and antiphospholipid syndrome

Am J Transplant. 2022 Oct;22(10):2464-2466. doi: 10.1111/ajt.17067. Epub 2022 May 5.

Authors

Emily Lin¹, Charles Bratton², Minh-Tri Nguyen², Joshua Chung³, Michael De Vera², Mina Rakoski^{1

4}

Affiliations

¹ Department of Medicine, Loma Linda University Medical Center, Loma Linda, California, USA.
² Department of Transplant Surgery, Loma Linda University Health, Loma Linda, California, USA.
³ Department of Cardiothoracic Surgery, Loma Linda University Health, Loma Linda, California, USA.
⁴ Transplantation Institute, Loma Linda University Health, Loma Linda, California, USA.

Abstract

Coexisting coronary artery disease (CAD), end-stage liver disease (ESLD), renal failure, and hypercoagulable state poses a formidable clinical challenge. Here, we discuss the first known case of a patient with antiphospholipid syndrome (APLS), ESLD complicated by hepatorenal syndrome (HRS), and severe CAD who successfully underwent combined coronary artery bypass grafting (CABG) and simultaneous liver/kidney (SLK) transplant.

Publication types

Case Reports

MeSH terms

Acute Kidney Injury*
Antiphospholipid Syndrome* / complications
Antiphospholipid Syndrome* / surgery
Coronary Artery Bypass
End Stage Liver Disease* / complications
End Stage Liver Disease* / surgery
Humans
Kidney
Kidney Failure, Chronic* / complications
Kidney Failure, Chronic* / surgery
Kidney Transplantation*
Treatment Outcome